Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple Sclerosis

NCT05078177 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Rituximab

Sponsor

St. Petersburg State Pavlov Medical University